{"entities":{"Q9625":{"pageid":13786,"ns":120,"title":"Item:Q9625","lastrevid":205548,"modified":"2020-05-21T15:39:04Z","type":"item","id":"Q9625","labels":{"en":{"language":"en","value":"Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9625$1BBE8253-8636-4F82-ACE5-B95DDC1EFF41","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9625$73C42643-E9AC-4329-866B-F8CFF98F2126","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Dey N","type":"string"},"datatype":"string"},"type":"statement","id":"Q9625$1028E825-DEFA-4E54-8A81-F8A6205EEEC6","rank":"normal"}],"P150":[{"mainsnak":{"snaktype":"value","property":"P150","datavalue":{"value":"De P","type":"string"},"datatype":"string"},"type":"statement","id":"Q9625$101B15E7-CCDD-4542-9D2A-3975CE83F74B","rank":"normal"}],"P151":[{"mainsnak":{"snaktype":"value","property":"P151","datavalue":{"value":"Leyland-Jones B","type":"string"},"datatype":"string"},"type":"statement","id":"Q9625$0C0C126C-B7BF-4091-847A-E76E2B26D3D3","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1016/j.pharmthera.2017.02.037","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9625$8EEEE2D7-025E-49E3-8E08-7D715D78FFFF","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"28216025","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9625$18CD77FF-CD55-4549-8B04-6EC49234C2D2","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2017-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9625$74336B8F-0F08-4F91-8A5A-A0AFAA2D93B4","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Pharmacol. Ther.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9625$A3F86D8A-51D5-4867-A15E-40D2E3756204","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"175","type":"string"},"datatype":"string"},"type":"statement","id":"Q9625$ACFFC503-F9C0-4507-9846-D3B24E2CF55E","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9625$C310963A-2DA8-4830-8350-4615515C2B09","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"91-106","type":"string"},"datatype":"string"},"type":"statement","id":"Q9625$31CB288C-3D7B-47AF-8473-80986FE79D59","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Dey_N,_et_al._Pharmacol._Ther._(2017)_cited_as_Ref_362_in_DOI:_10.1038/s41392-020-0110-5"}}}}}